Leishmania Trypanothione Synthetase-Amidase Structure Reveals a Basis for Regulation of Conflicting Synthetic and Hydrolytic Activities

Paul K. Fyfe, Sandra L. Oza, Alan H. Fairlamb, William N. Hunter

Journal of Biological Chemistry · 2008 · 99 citations · 46 references

DOIFull text

Open access

Concepts

Abstract

The bifunctional trypanothione synthetase-amidase catalyzes biosynthesis and hydrolysis of the glutathione-spermidine adduct trypanothione, the principal intracellular thiol-redox metabolite in parasitic trypanosomatids. These parasites are unique with regard to their reliance on trypanothione to determine intracellular thiol-redox balance in defense against oxidative and chemical stress and to regulate polyamine levels. Enzymes involved in trypanothione biosynthesis provide essential biological activities, and those absent from humans or for which orthologues are sufficiently distinct are attractive targets to underpin anti-parasitic drug discovery. The structure of Leishmania major trypanothione synthetase-amidase, determined in three crystal forms, reveals two catalytic domains. The N-terminal domain, a cysteine, histidine-dependent amidohydrolase/peptidase amidase, is a papain-like cysteine protease, and the C-terminal synthetase domain displays an ATP-grasp family fold common to C:N ligases. Modeling of substrates into each active site provides insight into the specificity and reactivity of this unusual enzyme, which is able to catalyze four reactions. The domain orientation is distinct from that observed in a related bacterial glutathionylspermidine synthetase. In trypanothione synthetase-amidase, the interactions formed by the C terminus, binding in and restricting access to the amidase active site, suggest that the balance of ligation and hydrolytic activity is directly influenced by the alignment of the domains with respect to each other and implicate conformational changes with amidase activity. The potential inhibitory role of the C terminus provides a mechanism to control relative levels of the critical metabolites, trypanothione, glutathionylspermidine, and spermidine in Leishmania. The bifunctional trypanothione synthetase-amidase catalyzes biosynthesis and hydrolysis of the glutathione-spermidine adduct trypanothione, the principal intracellular thiol-redox metabolite in parasitic trypanosomatids. These parasites are unique with regard to their reliance on trypanothione to determine intracellular thiol-redox balance in defense against oxidative and chemical stress and to regulate polyamine levels. Enzymes involved in trypanothione biosynthesis provide essential biological activities, and those absent from humans or for which orthologues are sufficiently distinct are attractive targets to underpin anti-parasitic drug discovery. The structure of Leishmania major trypanothione synthetase-amidase, determined in three crystal forms, reveals two catalytic domains. The N-terminal domain, a cysteine, histidine-dependent amidohydrolase/peptidase amidase, is a papain-like cysteine protease, and the C-terminal synthetase domain displays an ATP-grasp family fold common to C:N ligases. Modeling of substrates into each active site provides insight into the specificity and reactivity of this unusual enzyme, which is able to catalyze four reactions. The domain orientation is distinct from that observed in a related bacterial glutathionylspermidine synthetase. In trypanothione synthetase-amidase, the interactions formed by the C terminus, binding in and restricting access to the amidase active site, suggest that the balance of ligation and hydrolytic activity is directly influenced by the alignment of the domains with respect to each other and implicate conformational changes with amidase activity. The potential inhibitory role of the C terminus provides a mechanism to control relative levels of the critical metabolites, trypanothione, glutathionylspermidine, and spermidine in Leishmania. Parasitic Leishmania and Trypanosoma species cause serious tropical diseases such as kala-azar, African sleeping sickness, and Chagas diseases (1Reithinger R. Dujardin J.C. Louzir H. Pirmez C. Alexander B. Brooker S. Lancet Infect. Dis. 2007; 7: 581-596Abstract Full Text Full Text PDF PubMed Scopus (1049) Google Scholar, 2Barrett M.P. Boykin D.W. Brun R. Tidwell R.R. Br. J. Pharmacol. 2007; 152: 1155-1171Crossref PubMed Scopus (262) Google Scholar). The few drugs used to combat these infections are unsatisfactory due to issues of toxicity, high cost, poor efficacy, and increasing levels of drug resistance (3Croft S.L. Sundar S. Fairlamb A.H. Clin. Micro. Rev. 2006; 19: 111-126Crossref PubMed Scopus (1300) Google Scholar, 4Delespaux V. de Koning H.P. Drug Resist. Updat. 2007; 10: 30-50Crossref PubMed Scopus (232) Google Scholar). The detailed genomic and proteomic data now available for these organisms advance fundamental knowledge of eukaryote biology and provide opportunities to identify and exploit novel aspects of parasite metabolism in drug discovery (5Chaudhary K. Roos D.S. Nat. Biotechnol. 2005; 23: 1089-1091Crossref PubMed Scopus (63) Google Scholar). The search for new trypanocidal agents is focused on unique metabolic pathways found in the parasites such as those involved in polyamine metabolism (6Marton L.J. Pegg A.E. Annu. Rev. Pharmacol. Toxicol. 1995; 35: 55-91Crossref PubMed Scopus (711) Google Scholar, 8Heby O. Persson L. Rentala M. Amino Acids. 2007; 33: 359-366Crossref PubMed Scopus (150) Google Scholar) including the peptide-polyamine conjugate trypanothione (N1,N8-bis(glutathionyl)spermidine (T[SH]2), 2The abbreviations used are: T[SH]2, N1,N8-bis(glutathionyl)spermidine; GSPS, glutathionylspermidine synthetase amidase (EC 6.3.1.8; EC 3.5.1.78); r.m.s.d., root mean square deviation; TSA, trypanothione synthetase-amidase (EC 6.3.1.9; EC 3.5.1.78); LmTSA, L. major TSA; SeMet, selenomethionine; EcGSPS, E. coli GSPS. see Fig. 1 (9Fairlamb A.H. Cerami A. Annu. Rev. Microbiol. 1992; 46: 695-729Crossref PubMed Scopus (691) Google Scholar, 10Krauth-Siegel R.L. Bauer H. Schirmer R.H. Angew. Chem. Int. Ed. Engl. 2005; 44: 690-715Crossref PubMed Scopus (282) Google Scholar)). Mammals use glutathione (l-γ-Glu-Cys-Gly) in conjunction with glutathione reductase and glutathione peroxidase to regulate intracellular thiol levels and redox metabolism. Trypanosomatid parasites are different and exploit the properties of T[SH]2 together with the distinct enzymes trypanothione reductase, tryparedoxin, and tryparedoxin peroxidase to form the tryparedoxin peroxidase pathway, which contributes in defense against oxidative stress (9Fairlamb A.H. Cerami A. Annu. Rev. Microbiol. 1992; 46: 695-729Crossref PubMed Scopus (691) Google Scholar, 10Krauth-Siegel R.L. Bauer H. Schirmer R.H. Angew. Chem. Int. Ed. Engl. 2005; 44: 690-715Crossref PubMed Scopus (282) Google Scholar). This divergence from the host and reliance on different enzymes is of basic interest and the structure-function relationships for the tryparedoxin peroxidase pathway components have been elucidated (11Bond C.S. Zhang Y. Berriman M. Cunningham M.L. Fairlamb A.H. Hunter W.N. Structure. 1999; 7: 81-89Abstract Full Text Full Text PDF PubMed Scopus (193) Google Scholar, 12Alphey M.S. Leonard G.A. Gourley D.G. Tetaud E. Fairlamb A.H. Hunter W.N. J. Biol. Chem. 1999; 274: 25613-25622Abstract Full Text Full Text PDF PubMed Scopus (66) Google Scholar, 13Alphey M.S. Bond C.S. Tetaud E. Fairlamb A.H. Hunter W.N. J. Mol. Biol. 2000; 300: 903-916Crossref PubMed Scopus (141) Google Scholar, 14Alphey M.S. Gabrielsen M. Micossi E. Leonard G.A. McSweeney S.M. Ravelli R.B. Tetaud E. Fairlamb A.H. Bond C.S. Hunter W.N. J. Biol. Chem. 2003; 278: 25919-25925Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar). The host-parasite differences present opportunities to target trypanothione metabolism for drug discovery, and trypanothione reductase, for example, is a potential drug target (15Krieger S. Schwarz W. Ariyanayagam M.R. Fairlamb A.H. Krauth-Siegel R.L. Clayton C. Mol. Microbiol,. 2000; 35: 542-552Crossref PubMed Scopus (314) Google Scholar). We now focus on the enzyme responsible for the synthesis and degradation of T[SH]2, trypanothione synthetase-amidase (TSA). This enzyme is uniquely positioned to regulate the supply of T[SH]2, critical for maintenance of redox metabolism and the level of polyamines that are essential for cell proliferation and differentiation (6Marton L.J. Pegg A.E. Annu. Rev. Pharmacol. Toxicol. 1995; 35: 55-91Crossref PubMed Scopus (711) Google Scholar, 7Bacchi C.J. Yarlett N. Mini Rev. Med. Chem. 2002; 2: 553-563Crossref PubMed Scopus (53) Google Scholar, 8Heby O. Persson L. Rentala M. Amino Acids. 2007; 33: 359-366Crossref PubMed Scopus (150) Google Scholar). TSA activity was first identified in the model trypanosomatid Crithidia fasciculata (16Henderson G.B. Yamaguchi M. Novoa L. Fairlamb A.H. Cerami A. Biochemistry. 1990; 29: 3924-3929Crossref PubMed Scopus (37) Google Scholar, 17Smith K. Nadeau K. Bradley M. Walsh C. Fairlamb A.H. Protein Sci. 1992; 1: 874-883Crossref PubMed Scopus (67) Google Scholar). Subsequently it was observed that the active enzyme is actually a TSA glutathionylspermidine synthetase (GSPS) heterodimer (18Tetaud E. Manai F. Barrett M.P. Nadeau K. Walsh C.T. Fairlamb A.H. J. Biol. Chem. 1998; 273: 19383-19390Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar, 19Comini M. Menge U. Wissing J. Flohé L. J. Biol. Chem. 2005; 280: 6850-6860Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). In the human pathogens, Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, and Leishmania donovani, a monomeric protein, mass ∼74 kDa, is responsible for TSA activity (20Oza S.L. Tetaud E. Ariyanayagam M.R. Warnon S.S. Fairlamb A.H. J. Biol. Chem. 2002; 277: 35853-35861Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar, 21Comini M. Guerrero S.A. Haile S. Menge U. Lünsdorf H. Flohé L. Free Radic. Biol. Med. 2004; 36: 1289-1302Crossref PubMed Scopus (102) Google Scholar, 22Oza S.L. Shaw M.P. Wyllie S. Fairlamb A.H. Mol. Biochem. Parasitol. 2005; 139: 107-116Crossref PubMed Scopus (81) Google Scholar, 23Ariyanayagam M.R. Oza S.L. Guther M.L. Fairlamb A.H. Biochem. J. 2005; 391: 425-432Crossref PubMed Scopus (70) Google Scholar, 24Oza S.L. Wyllie S. Fairlamb A.H. Mol. Biochem. Parasitol. 2006; 149: 117-120Crossref PubMed Scopus (6) Google Scholar, 25Oza S.L. Ariyanayagam M.R. Aitcheson N. Fairlamb A.H. Mol. Biochem. Parasitol. 2003; 131: 25-33Crossref PubMed Scopus (62) Google Scholar) and catalyzes four reactions by acting as a GSPS, a trypanothione synthetase, a trypanothione amidase, and a glutathionylspermidine amidase. Based on similarities to Escherichia coli GSPS (EcGSPS), TSA is predicted to comprise two domains with separate activities (26Bollinger Jr., J.M. Kwon D.S. Huisman G.W. Kolter R. Walsh C.T. J. Biol. Chem. 1995; 270: 14031-14041Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar, 27Kwon D.S. Lin C.H. Chen S.J. Coward J.K. Walsh C.T. Bollinger Jr., J.M. J. Biol. Chem. 1997; 272: 2429-2436Abstract Full Text Full Text PDF PubMed Scopus (47) Google Scholar, 28Pai C.H. Chiang C.C. Ko T.P. Chou C.C. Chong C.M. Yen F.J. Chen S. Coward J.K. Wang A.H.J. Lin C.H. EMBO J. 2006; 25: 5970-5982Crossref PubMed Scopus (47) Google Scholar). The C-terminal domain catalyzes T[SH]2 biosynthesis by the stepwise addition of two molecules of glutathione (GSH) onto spermidine with hydrolysis of two ATP molecules (Fig. 1). The N-terminal domain is capable of hydrolyzing T[SH]2 and/or glutathionylspermidine back to spermidine and glutathione (Fig. 1) and is classified as a cysteine-histidine-dependent amidohydrolase/peptidase amidase (29Bateman A. Rawlings N.D. Trends Biochem. Sci. 2003; 28: 234-237Abstract Full Text Full Text PDF PubMed Scopus (185) Google Scholar, 30Rigden D.J. Jedrzejas M.J. Galperin M.Y. Trends Biochem. Sci. 2003; 28: 230-234Abstract Full Text Full Text PDF PubMed Scopus (127) Google Scholar). TSA is important in T. brucei as shown by RNA interference experiments, which indicate a loss of proliferation and viability with increased sensitivity to oxidative stress (21Comini M. Guerrero S.A. Haile S. Menge U. Lünsdorf H. Flohé L. Free Radic. Biol. Med. 2004; 36: 1289-1302Crossref PubMed Scopus (102) Google Scholar, 22Oza S.L. Shaw M.P. Wyllie S. Fairlamb A.H. Mol. Biochem. Parasitol. 2005; 139: 107-116Crossref PubMed Scopus (81) Google Scholar). Such data are consistent with studies on T. cruzi where TSA inhibitors trypanocidal R. J. Med. Chem. 2006; Scopus Google Scholar). These suggest that the enzyme is a potential drug present the structure of the L. major enzyme determined in three crystal We have been to of TSA similarities with related in and cysteine to and the of specificity and These to a balance or regulate and hydrolytic reactions that determine the critical levels of and was by S.L. Shaw M.P. Wyllie S. Fairlamb A.H. Mol. Biochem. Parasitol. 2005; 139: 107-116Crossref PubMed Scopus (81) Google Scholar). was the E. coli in with where was with M.S. Leonard G.A. Gourley D.G. Tetaud E. Fairlamb A.H. Hunter W.N. J. Biol. Chem. 1999; 274: 25613-25622Abstract Full Text Full Text PDF PubMed Scopus (66) Google Scholar). Full of was by of mass in 1 and 1 Protein was determined the E. C. A. S. M.R. A. J.M. The Google Scholar). crystal with the and to in The from 1 of with 1 of for crystal form to a of crystal form to and and crystal form to and and properties and and by for in with used directly from the on a and and in to The and and by in the of and of these was in and the data for form and on and an and a and for form on with an data from a form crystal on and with W. J. Scopus Google Scholar) or a and on Protein Scholar) Biol. 2006; PubMed Scopus Google Scholar, Biol. PubMed Scopus Google Scholar) and are in cell in to the where is the of the of and is the mean of for where is the observed structure and the is the from the is the as with a of data that are from in to the of from for in to the where is the of the of and is the mean of for where is the observed structure and the is the from the is the as with a of data that are from in a new and by of the identified the J. Biol. 1999; PubMed Scopus Google Scholar) a of for data to and a of and was the Biol. 2000; PubMed Scopus Google Scholar) and increased the to data on a crystal to an of with the to to a which formed the for model in the K. Biol. 2004; PubMed Scopus Google Scholar). The model this form available and data to of and the form model was used for with A. A. J. 1997; Scopus Google Scholar). molecules positioned an of and a of The by with Fig. The was to a model with for each was A. Biol. 1999; PubMed Scopus Google Scholar) with M. M. Biol. PubMed Scopus Google model and of molecules and this model was used to the other crystal by and de J.M. J. 2003; PubMed Scopus Google Scholar) was used to the model with the in and D.S. J.M. J. Google and The Scholar). and of domain and used W. A. Scopus Google R. S. 2005; PubMed Scopus Google and E. K. Biol. 2004; PubMed Scopus Google Scholar). and used to model and model are in structure of was determined with from a to a The model from this was used to determine the of two crystal forms, of which to The and model 1) indicate that the have The from the three crystal are The root mean square from of of the different from to with an of The crystal two molecules in the and with an of are three and and and and and and the high of the it is to and have A. and of are in Fig. to the structure in Fig. an N-terminal amidase domain of and and C-terminal synthetase domain of The amidase domain displays a papain-like V. L. 2003; Scopus Google with two and and a by (Fig. The synthetase domain three and displays the ATP-grasp fold (Fig. M.Y. Protein Sci. 1997; PubMed Scopus Google Scholar)). and a is of this the other an to C where ATP of a with on and on the and a of to to the C which as of the ATP binding This a and and with and of the The and and and are Such the of the are a of ATP-grasp A. L. Structure. 2002; 10: Full Text Full Text PDF PubMed Scopus Google Scholar, T. H. Y. O. Biochemistry. 35: PubMed Scopus (66) Google Scholar) and are the ATP binding to the C-terminal of which to The and C-terminal from the amidase and synthetase (Fig. The terminus an and of the synthetase The C-terminal actually to the amidase domain with for of amidase this The of molecules in the three crystal forms, or is with N-terminal from the ATP binding site of the Fig. This is an of important for the of the crystal and to by crystal or the of specificity and identified related for The of and and this to domains. of the amidase domains an of for the for of the synthetase domain is of synthetase domains reveals a in the relative orientation of the amidase domains (Fig. with a of of The and of this is by the of the major in the amidase domain in the two (Fig. In from the synthetase domain with the amidase active site to the in EcGSPS, is to The of that from amidase to synthetase domains in and are different (Fig. In the from the of the to the first in the synthetase domain The in is with is by the C terminus, and this with amidase and synthetase domains. The relative orientation and of the amidase and synthetase domains distinct in the two enzymes and in distinct amidase active The amidase active site is in the of a on the of the N-terminal domain In the domain in conjunction with the structure of the C terminus the catalytic site a The synthetase domain displays the ATP-grasp which in a We identified as the related structure to LmTSA, and a of the synthetase domains an of glutathione synthetase is with a of of with glutathione synthetase an of These indicate that the synthetase active of human glutathione synthetase, EcGSPS, and are and the of important for ATP and glutathione binding Fig. to model the of reactions and 1 and with the structure of in with an that a C.H. Chiang C.C. Ko T.P. Chou C.C. Chong C.M. Yen F.J. Chen S. Coward J.K. Wang A.H.J. Lin C.H. EMBO J. 2006; 25: 5970-5982Crossref PubMed Scopus (47) Google Scholar) to the spermidine in This model was to glutathionylspermidine by the to We to or of the for two are in this of the synthetase domain, and this in conjunction with the high of of glutathionylspermidine, such The synthetase active site is a that each of the three substrates the of the The catalytic is the The ATP binding site and the is formed by and the site and is a and (Fig. The ATP binding site is formed by the of and the of C. are two of these that with and with of the ATP-grasp family of enzymes is the of such the binding site that on a T. H. Y. O. Biochemistry. 35: PubMed Scopus (66) Google Scholar). is predicted to in a by and two to the on the of and of a from the of and a from of these directly in are in and The and of LmTSA, to and in EcGSPS, and In are in and important for binding and orientation of the of ATP A. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). In these are and The basic and are to with in the ATP-grasp and which in with the of These interactions and the to in the synthetase to form the and and the is the of the catalytic site and is in with a to the of The is to the with to and the with and an to spermidine by a identify two binding C.H. Chiang C.C. Ko T.P. Chou C.C. Chong C.M. Yen F.J. Chen S. Coward J.K. Wang A.H.J. Lin C.H. EMBO J. 2006; 25: 5970-5982Crossref PubMed Scopus (47) Google Scholar). The of this a formed by the and with the other by the that to This is the binding The and interactions with and in C.H. Chiang C.C. Ko T.P. Chou C.C. Chong C.M. Yen F.J. Chen S. Coward J.K. Wang A.H.J. Lin C.H. EMBO J. 2006; 25: 5970-5982Crossref PubMed Scopus (47) Google Scholar). The first three of these are in GSPS and TSA and in is in GSPS and or in TSA in of is by in TSA in and or in GSPS. In the glutathione the in a that from ATP and binding This is by a spermidine in the and is the polyamine binding glutathione the site, it a with and the an with C.H. Chiang C.C. Ko T.P. Chou C.C. Chong C.M. Yen F.J. Chen S. Coward J.K. Wang A.H.J. Lin C.H. EMBO J. 2006; 25: 5970-5982Crossref PubMed Scopus (47) Google Scholar). This is with synthetase activity. of in GSPS to in a in for and and C.H. Chiang C.C. Ko T.P. Chou C.C. Chong C.M. Yen F.J. Chen S. Coward J.K. Wang A.H.J. Lin C.H. EMBO J. 2006; 25: 5970-5982Crossref PubMed Scopus (47) Google Scholar) suggest that this binding site regulate the enzyme with a mechanism to in the of is in TSA, where it is by in The of with the which the structure was have the of by the to glutathione in a the in the such The N-terminal of and the of LmTSA, with from and the to The these two is as is the and that conformational changes on the of the polyamine In EcGSPS, two and and the of are predicted to form with the spermidine of the and by these are interactions that the polyamine in the is and are in this of is and to a to an to with the polyamine The in and the to in in TSA, is on the of the and to with and polyamine In a alignment this with of The of and and of where the substrates TSA catalyzes two reactions to an In (Fig. the and are by and with the of the of and the of spermidine the of the synthetase active site (Fig. The is by the of an The is and the by from and two The on the which to an with of and in a to that for glutathione synthetase (EC and synthetase J. Chem. 2005; PubMed Scopus Google Scholar). The the active site (Fig. 1) the and are by ATP and in (Fig. with the from the active site, and the the catalytic to trypanothione, and The differences the synthetase domains of and are to the of the where the is poor Fig. This in of the in the site glutathionylspermidine, the by to the (26Bollinger Jr., J.M. Kwon D.S. Huisman G.W. Kolter R. Walsh C.T. J. Biol. Chem. 1995; 270: 14031-14041Abstract Full Text Full Text PDF PubMed Scopus (85) Google and The amidase active site is the N-terminal of identified as the catalytic cysteine S.L. Ariyanayagam M.R. Fairlamb A.H. Biochem. J. 2002; PubMed Scopus Google Scholar). The catalytic is by and (Fig. The of cysteine is R. PubMed Scopus Google Scholar). of the amidase domain of with a structure in the active site M.S. Hunter W.N. Biol. 2006; PubMed Scopus Google Scholar) important similarities and and on the orientation of the to with respect to the catalytic In LmTSA, the C-terminal is on of (Fig. is on the the terminus of the is positioned on the other of We these to the of a and a the of a The amidase mechanism a with by a to the of a by onto the to form an In (Fig. hydrolysis of the an glutathione and In the is formed with glutathionylspermidine, and glutathione and related of the amidase active site are the of in In the in with the of the catalytic cysteine, an to the on the by the of an R. PubMed Scopus Google Scholar). for to a a different and is the that the of the C-terminal is into the amidase active site, with into a The C terminus of from the synthetase domain to with the amidase domain and The C-terminal of Leishmania TSA are and Fig. The three in are These in and interactions with basic that the amidase and synthetase domains in the observed and access to the catalytic (Fig. with and with in addition to a with The C-terminal on with and and the by and with the synthetase active site, to with or into the amidase active site We this to the of the C-terminal the active alignment of the C terminus in the active site and with the Fig. indicate substrates are for the with respect to for of trypanothione the (Fig. the to access to the catalytic The spermidine and other components are of the active site an and are to and with the (Fig. the catalytic site and with the of the of (Fig. glutathionylspermidine with the as the spermidine the of the the hydrolytic to The of a of glutathionylspermidine hydrolysis the synthetase substrates and ATP are present and to a of amidase on the domain is from the synthetase domain D.S. Lin C.H. Chen S.J. Coward J.K. Walsh C.T. Bollinger Jr., J.M. J. Biol. Chem. 1997; 272: 2429-2436Abstract Full Text Full Text PDF PubMed Scopus (47) Google Scholar). This or of enzyme The to the amidase active site, the synthetase domain, is by a The enzyme is a the is from the amidase active site and the mechanism of or in that enzyme to a N-terminal amidase domain of have The C-terminal of the contributes to the amidase domain and loss the The bifunctional TSA regulate or balance amidase and synthetase activities to the relative of glutathionylspermidine, and In the structure of the C terminus, which the amidase active site, provides the mechanism to regulate such activity a conformational is to the active site for This from changes in domain orientation or by The responsible for the C terminus in the amidase active site are in Leishmania and C. fasciculata TSA with the of in the enzyme, by In Trypanosoma species the the C-terminal from Leishmania and C. fasciculata TSA Fig. This differences this of the amidase active site a different of studies are to this in We the for and with

References

46